What drug company makes dapagliflozin?

What drug company makes dapagliflozin?

AstraZeneca and Bristol-Myers Squibb Company announced the US Food and Drug Administration (FDA) approved FARXIGA™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.

What class of drug is dapagliflozin?

Dapagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

Is dapagliflozin approved by the FDA?

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

What is dapagliflozin used for NHS?

Dapagliflozin is mainly used to treat type 2 diabetes. It can also be used to treat heart failure. Dapagliflozin is usually prescribed if: you have type 2 diabetes and cannot take metformin.

Is there a generic dapagliflozin?

About Farxiga Farxiga (dapagliflozin) helps to treat type 2 diabetes, heart failure, and chronic kidney disease. It helps to control blood sugar. There are currently no generic alternatives to Farxiga.

What is the generic of dapagliflozin?

Farxiga (dapagliflozin) is a type 2 diabetes medication jointly developed by AstraZeneca and Bristol-Myers Squibb (BMS). It is called Forxiga in Canada and Europe, where it has been approved since November 2012.

Is dapagliflozin available in generic?

The US Food and Drug Administration (FDA), on February 23, finalized its decision approving the therapeutic equivalence of a generic formulation of the SGLT2 inhibitor dapagliflozin made by Zydus Pharmaceuticals to the branded version, Farxiga, that is marketed by AstraZeneca.

When did dapagliflozin get approved for heart failure?

In 2019, dapagliflozin was approved by the FDA to reduce hospitalization risk for heart failure in adults with T2D and established CV disease or risk factors.

Is dapagliflozin licensed for heart failure?

Licensed indication Dapagliflozin is now licensed for the treatment of adults (with or without diabetes) with symptomatic chronic heart failure with reduced ejection fraction (≤40%).

Is there a cheaper alternative to Farxiga?

Glipizide Glipizide is a generic medication with a significantly lower cost compared to Farxiga.

How can I get free Farxiga?

Savings Card Registration With the FARXIGA SavingsRx Card, most commercially insured patients can get FARXIGA for as little as $0* per month for as long as their doctor prescribes any available dose. You can even register to receive savings and prescription refill reminders via text!

Is there a generic version of Forxiga?

There are currently no generic alternatives to Farxiga in the United States.

How much is a 30 day supply of Farxiga?

The cost for Farxiga oral tablet 5 mg is around $587 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Can you take dapagliflozin at night?

You can take dapagliflozin any time of day, just try to take it at the same time every day.

Is Farxiga better than metformin?

Farxiga has an average rating of 4.5 out of 10 from a total of 129 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 51% reported a negative effect. Metformin has an average rating of 6.9 out of 10 from a total of 611 ratings on Drugs.com.

Is dapagliflozin a new drug?

Dapagliflozin (Forxiga) was authorised in 2019 as an adjunct to insulin in patients with type 1 diabetes with a body-mass index (BMI) of 27 kg per m2 or higher, when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy.

How long has dapagliflozin been on the market?

Development timeline for Farxiga

Date	Article
Oct 21, 2019	Approval FDA Approves Farxiga (dapagliflozin) to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes
Jan 8, 2014	Approval FDA Approves Farxiga to Treat Type 2 Diabetes

When was Farxiga heart failure?

In October 2019 the US FDA approved FARXIGA to reduce the risk of hospitalization for HF in adult patients with T2D and established CV disease or multiple CV risk factors. The approval was based on the DECLARE-TIMI 58 trial.

What is a good replacement for Farxiga?

Top 5 Farxiga alternatives

• Jardiance. Like Farxiga, Jardiance is an SGLT2 inhibitor.
• Glipizide. Glipizide is a generic medication with a significantly lower cost compared to Farxiga.
• Metformin.
• Januvia.
• Rybelsus.